|
| Status |
Public on May 26, 2021 |
| Title |
Genome-scale CRISPR-Cas9 screen of Wnt/β-catenin signalling identifies therapeutic targets for Colorectal Cancer |
| Organism |
Homo sapiens |
| Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
34138730 |
|
https://doi.org/10.1126/sciadv.abf2567
|
| |
| Submission date |
Aug 12, 2020 |
| Last update date |
Jul 15, 2021 |
| Contact name |
Ron Firestein |
| E-mail(s) |
[email protected]
|
| Organization name |
Hudson Institute of Medical Research
|
| Department |
CCR
|
| Lab |
Functional Genomics
|
| Street address |
21 Wright street
|
| City |
Clayton |
| State/province |
VIC |
| ZIP/Postal code |
3168 |
| Country |
Australia |
| |
|
| Platforms (2) |
|
| Samples (20)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE156081 |
Genome-scale CRISPR-Cas9 screen of Wnt/β-catenin signalling identifies therapeutic targets for Colorectal Cancer (ChIP-seq) |
| GSE156082 |
Genome-scale CRISPR-Cas9 screen of Wnt/β-catenin signalling identifies therapeutic targets for Colorectal Cancer (RNA-seq) |
|
| Relations |
| BioProject |
PRJNA656718 |
Less...
More...